Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects (Q34118531)

31 July 2017

title

Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects (English)

1 reference

31 July 2017

1 reference

1 reference

chronic heart failure

1 reference

Tan LB

1

1 reference

31 July 2017

Murray RG

series ordinal

2

1 reference

31 July 2017

Littler WA

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

1 August 1987

1 reference

31 July 2017

published in

British Heart Journal

1 reference

31 July 2017

volume

58

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

122-128

1 reference

Acute haemodynamic and metabolic effects of felodipine in congestive heart failure

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Hemodynamic effects of vasodilators and long-term response in heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Perceived exertion as an indicator of somatic stress

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Vascular selectivity of felodipine.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Felodipine in ventricular dysfunction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Acute haemodynamic effects of felodipine in congestive heart failure.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Importance of internal controls, statistical methods, and side effects in short-term trials of vasodilators: a study of hydralazine kinetics in patients with aortic regurgitation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Vasodilator therapy of cardiac failure: (first of two parts)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

The role of vasodilator therapy in heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1277290

Combination vasodilator therapy for severe chronic congestive heart failure

28 October 2018

1 reference

12 December 2020

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

1 reference

12 December 2020

Vasodilator therapy--a physiologic approach to the treatment of heart failure

1 reference

12 December 2020

Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

1 reference

12 December 2020

Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo

1 reference

12 December 2020

Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses

1 reference

12 December 2020

Editorial: Vasodilator therapy for heart failure

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.58.2.122

1 reference

31 July 2017

1 reference

31 July 2017

1 reference